Standard Biotools (LAB) Amortizatization of Intangibles (2010 - 2026)
Standard Biotools' (LAB) quarterly Amortizatization of Intangibles came in at $632000.0 in Q1 2026, down 24.85% year-on-year from $841000.0 in Q1 2025, and up 36.8% on a QoQ basis from $462000.0 in Q4 2025.
Standard Biotools (LAB) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has 7 years of Amortizatization of Intangibles data on file, last reported at $632000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 24.85% year-over-year to $632000.0 in Q1 2026; TTM through Mar 2026 was $2.4 million, a 56.64% decrease from a year earlier, with the FY2025 full-year figure at $2.6 million, down 64.44% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $632000.0, up from $462000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for LAB reached as high as $2.7 million in Q1 2024 and fell as low as -$14000.0 in Q2 2023.
- Historically, Amortizatization of Intangibles has averaged $920923.1 across 4 years, with a median of $730000.0 in 2025.
- Across the five-year window, Amortizatization of Intangibles jumped 13557.14% in 2024 and slumped 68.38% in 2025, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $940000.0 in 2023, then grew by 20.43% to $1.1 million in 2024, then tumbled by 59.19% to $462000.0 in 2025, then soared by 36.8% to $632000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $632000.0 in Q1 2026, $462000.0 in Q4 2025, and $611000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Standard Biotools | 299.46 Mn | -155.72 Mn | 11.31 Mn | 632,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 632,000.00 |
| Mar 31, 2026 | 632,000.00 |
| Dec 31, 2025 | 462,000.00 |
| Dec 31, 2025 | 462,000.00 |
| Sep 30, 2025 | 611,000.00 |
| Sep 30, 2025 | 611,000.00 |
| Jun 30, 2025 | 730,000.00 |
| Jun 30, 2025 | 730,000.00 |
| Mar 31, 2025 | 841,000.00 |
| Mar 31, 2025 | 841,000.00 |
| Dec 31, 2024 | 1.13 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Mar 31, 2024 | 2.66 Mn |
| Mar 31, 2024 | 2.66 Mn |
| Dec 31, 2023 | 940,000.00 |
| Dec 31, 2023 | 940,000.00 |